176 related articles for article (PubMed ID: 19113861)
1. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Guerrini R; Camarda V; Trapella C; Calò G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2009 Jan; 52(2):524-9. PubMed ID: 19113861
[TBL] [Abstract][Full Text] [Related]
2. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
Guerrini R; Camarda V; Trapella C; Caló G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2009 Jul; 52(13):4068-71. PubMed ID: 19473027
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
Camarda V; Trapella C; Calo G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
J Med Chem; 2008 Feb; 51(3):655-8. PubMed ID: 18181564
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
[TBL] [Abstract][Full Text] [Related]
5. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
[TBL] [Abstract][Full Text] [Related]
6. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity study at positions 3 and 4 of human neuropeptide S.
Camarda V; Trapella C; Calo' G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
Bioorg Med Chem; 2008 Oct; 16(19):8841-5. PubMed ID: 18793857
[TBL] [Abstract][Full Text] [Related]
9. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
Roth AL; Marzola E; Rizzi A; Arduin M; Trapella C; Corti C; Vergura R; Martinelli P; Salvadori S; Regoli D; Corsi M; Cavanni P; Caló G; Guerrini R
J Biol Chem; 2006 Jul; 281(30):20809-20816. PubMed ID: 16720571
[TBL] [Abstract][Full Text] [Related]
11. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor.
Peng YL; Han RW; Chang M; Zhang L; Zhang RS; Li W; Han YF; Wang R
Peptides; 2010 Dec; 31(12):2259-63. PubMed ID: 20800637
[TBL] [Abstract][Full Text] [Related]
12. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
Tancredi T; Guerrini R; Marzola E; Trapella C; Calo G; Regoli D; Reinscheid RK; Camarda V; Salvadori S; Temussi PA
J Med Chem; 2007 Sep; 50(18):4501-8. PubMed ID: 17696420
[TBL] [Abstract][Full Text] [Related]
13. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.
Clark SD; Kenakin TP; Gertz S; Hassler C; Gay EA; Langston TL; Reinscheid RK; Runyon SP
Neuropharmacology; 2017 May; 118():69-78. PubMed ID: 28267583
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide S receptor ligands: a patent review (2005-2016).
Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
[TBL] [Abstract][Full Text] [Related]
15. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.
Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G
Peptides; 2013 Jan; 39():16-20. PubMed ID: 23142110
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Leonard SK; Dwyer JM; Sukoff Rizzo SJ; Platt B; Logue SF; Neal SJ; Malberg JE; Beyer CE; Schechter LE; Rosenzweig-Lipson S; Ring RH
Psychopharmacology (Berl); 2008 May; 197(4):601-11. PubMed ID: 18311561
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
[TBL] [Abstract][Full Text] [Related]
20. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
